Marija Kuna1, Jamarius P Waller2, Omar C Logue2, Gene L Bidwell3. 1. Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA. 2. Department of Neurology, University of Mississippi Medical Center, Jackson, MS, USA. 3. Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA; Department of Neurology, University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: gbidwell@umc.edu.
Abstract
INTRODUCTION: Fusion of therapeutic agents to Elastin-like Polypeptide (ELP) is a novel drug delivery strategy for prevention of placental drug transfer. Previous studies have used a 60 kDa ELP tag for this purpose. However, placental transfer of ELP may be size dependent. The goal of this study was to measure the effects of ELP polymer size on pharmacokinetics, biodistribution, and placental transfer of ELP. METHODS: Three ELPs ranging from 25 to 86 kDa (4.1-6.8 nm hydrodynamic radius) were fluorescently labeled and administered by i.v. bolus to pregnant Sprague Dawley rats on gestational day 14. Plasma levels were monitored for 4 h, organ levels and placental transfer determined by ex vivo fluorescence imaging, and placental localization determined by confocal microscopy. RESULTS: Increasing ELP size resulted in slower plasma clearance and increased deposition in all major maternal organs, except in the kidneys where an opposite effect was observed. Placental levels increased with an increase in size, while in the pups, little to no ELP was detected. DISCUSSION: Pharmacokinetics and biodistribution of ELPs during pregnancy are size dependent, but all ELPs tested were too large to traverse the placental barrier. These studies verify that ELP fusion is a powerful method of modulating half-life and preventing placental transfer of cargo molecules. The tunable nature of the ELP sequence makes it ideal for drug delivery applications during pregnancy, where it can be used to target drugs to the mother while preventing fetal drug exposure.
INTRODUCTION: Fusion of therapeutic agents to Elastin-like Polypeptide (ELP) is a novel drug delivery strategy for prevention of placental drug transfer. Previous studies have used a 60 kDa ELP tag for this purpose. However, placental transfer of ELP may be size dependent. The goal of this study was to measure the effects of ELPpolymer size on pharmacokinetics, biodistribution, and placental transfer of ELP. METHODS: Three ELPs ranging from 25 to 86 kDa (4.1-6.8 nm hydrodynamic radius) were fluorescently labeled and administered by i.v. bolus to pregnant Sprague Dawley rats on gestational day 14. Plasma levels were monitored for 4 h, organ levels and placental transfer determined by ex vivo fluorescence imaging, and placental localization determined by confocal microscopy. RESULTS: Increasing ELP size resulted in slower plasma clearance and increased deposition in all major maternal organs, except in the kidneys where an opposite effect was observed. Placental levels increased with an increase in size, while in the pups, little to no ELP was detected. DISCUSSION: Pharmacokinetics and biodistribution of ELPs during pregnancy are size dependent, but all ELPs tested were too large to traverse the placental barrier. These studies verify that ELP fusion is a powerful method of modulating half-life and preventing placental transfer of cargo molecules. The tunable nature of the ELP sequence makes it ideal for drug delivery applications during pregnancy, where it can be used to target drugs to the mother while preventing fetal drug exposure.
Authors: Eric M George; Fakhri Mahdi; Omar C Logue; Grant G Robinson; Gene L Bidwell Journal: J Ocul Pharmacol Ther Date: 2015-12-16 Impact factor: 2.671
Authors: Alejandro R Chade; Nathan A Tullos; Taylor W Harvey; Fakhri Mahdi; Gene L Bidwell Journal: J Am Soc Nephrol Date: 2015-11-05 Impact factor: 10.121
Authors: Peter Wick; Antoine Malek; Pius Manser; Danielle Meili; Xenia Maeder-Althaus; Liliane Diener; Pierre-Andre Diener; Andreas Zisch; Harald F Krug; Ursula von Mandach Journal: Environ Health Perspect Date: 2009-11-12 Impact factor: 9.031
Authors: Jamarius P Waller; John Aaron Howell; Hali Peterson; Eric M George; Gene L Bidwell Journal: Hypertension Date: 2021-11-01 Impact factor: 10.190
Authors: Adrian C Eddy; John Aaron Howell; Heather Chapman; Erin Taylor; Fakhri Mahdi; Eric M George; Gene L Bidwell Journal: Hypertension Date: 2019-12-02 Impact factor: 10.190
Authors: Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day Journal: Adv Drug Deliv Rev Date: 2020-09-28 Impact factor: 15.470